Annual Short Term Debt
$1.30 M
+$89.00 K+7.35%
31 December 2023
Summary:
Cidara Therapeutics annual short term debt is currently $1.30 million, with the most recent change of +$89.00 thousand (+7.35%) on 31 December 2023. During the last 3 years, it has fallen by -$6.66 million (-83.67%). CDTX annual short term debt is now -87.94% below its all-time high of $10.78 million, reached on 31 December 2019.CDTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$1.58 M
+$59.00 K+3.88%
30 September 2024
Summary:
Cidara Therapeutics quarterly short term debt is currently $1.58 million, with the most recent change of +$59.00 thousand (+3.88%) on 30 September 2024. Over the past year, it has increased by +$530.00 thousand (+50.43%). CDTX quarterly short term debt is now -85.38% below its all-time high of $10.81 million, reached on 31 March 2020.CDTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.3% | +50.4% |
| 3 y3 years | -83.7% | -66.6% |
| 5 y5 years | -86.9% | -85.3% |
CDTX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.7% | +7.3% | -66.6% | +67.8% |
| 5 y | 5 years | -87.9% | +7.3% | -85.4% | +67.8% |
| alltime | all time | -87.9% | +7.3% | -85.4% | +137.0% |
Cidara Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.58 M(+3.9%) |
| June 2024 | - | $1.52 M(+4.0%) |
| Mar 2024 | - | $1.46 M(+12.6%) |
| Dec 2023 | $1.30 M(+7.3%) | $1.30 M(+23.7%) |
| Sept 2023 | - | $1.05 M(+11.6%) |
| June 2023 | - | $942.00 K(-5.9%) |
| Mar 2023 | - | $1.00 M(-17.3%) |
| Dec 2022 | $1.21 M(-67.6%) | $1.21 M(-5.2%) |
| Sept 2022 | - | $1.28 M(-20.3%) |
| June 2022 | - | $1.60 M(-40.0%) |
| Mar 2022 | - | $2.67 M(-28.6%) |
| Dec 2021 | $3.74 M | $3.74 M(-20.9%) |
| Sept 2021 | - | $4.73 M(-10.6%) |
| June 2021 | - | $5.29 M(-20.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $6.63 M(-16.7%) |
| Dec 2020 | $7.96 M(-26.2%) | $7.96 M(-11.9%) |
| Sept 2020 | - | $9.04 M(-10.6%) |
| June 2020 | - | $10.11 M(-6.5%) |
| Mar 2020 | - | $10.81 M(+0.3%) |
| Dec 2019 | $10.78 M(+8.6%) | $10.78 M(+0.3%) |
| Sept 2019 | - | $10.75 M(+0.4%) |
| June 2019 | - | $10.71 M(+0.4%) |
| Mar 2019 | - | $10.67 M(+7.5%) |
| Dec 2018 | $9.93 M(+272.3%) | $9.93 M(+1388.5%) |
| Sept 2018 | - | $667.00 K(-68.0%) |
| Mar 2018 | - | $2.08 M(-21.9%) |
| Dec 2017 | $2.67 M | $2.67 M(+60.0%) |
| Sept 2017 | - | $1.67 M(+149.9%) |
| June 2017 | - | $667.00 K |
FAQ
- What is Cidara Therapeutics annual short term debt?
- What is the all time high annual short term debt for Cidara Therapeutics?
- What is Cidara Therapeutics annual short term debt year-on-year change?
- What is Cidara Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly short term debt year-on-year change?
What is Cidara Therapeutics annual short term debt?
The current annual short term debt of CDTX is $1.30 M
What is the all time high annual short term debt for Cidara Therapeutics?
Cidara Therapeutics all-time high annual short term debt is $10.78 M
What is Cidara Therapeutics annual short term debt year-on-year change?
Over the past year, CDTX annual short term debt has changed by +$89.00 K (+7.35%)
What is Cidara Therapeutics quarterly short term debt?
The current quarterly short term debt of CDTX is $1.58 M
What is the all time high quarterly short term debt for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly short term debt is $10.81 M
What is Cidara Therapeutics quarterly short term debt year-on-year change?
Over the past year, CDTX quarterly short term debt has changed by +$530.00 K (+50.43%)